Scaling vaccine manufacturing productivity: achieving a 20x viral titer increase in cell cultures

Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Scaling vaccine manufacturing productivity: achieving a 20x viral titer increase in cell cultures

Live30 webinars pack the latest innovations and applications into a data-rich 30-minute session.

Would you like to gain insights into a change in culture vessel which delivered a 20x increase in viral titer, a 15% reduction in media volume per cm³, and measurable gains in cleanroom efficiency for a cell-based vaccine process? This webinar will walk through the process development data behind that shift and the practical parameters that make it work.

Presenters will cover the critical process parameters affecting viral titer, the impact of surface area and media conditions on productivity, and how streamlined vessel handling supports scalable, contamination-controlled operations.

Attend this webinar to:

Review real-world scale-up data from this vaccine manufacturing case study, including a 20x productivity gain and 15% reduction in media volume
Identify the process parameters that most influence viral titer during adherent scale-up, from surface area to culture conditions
Apply strategies for improving cell growth environments to support higher viral replication and yield
Assess how reduced vessel manipulation lowers contamination risk and operational demand in the cleanroom

Irana Coletti Malaspina

Field Application Scientist at Corning Life Sciences

Irana Coletti Malaspina is a Biologist with a Master’s degree in Industrial Engineering, currently wor

Irana Coletti Malaspina is a Biologist with a Master’s degree in Industrial Engineering, currently working as Field Application Scientist for Corning Life Sciences in the South America Region. Her background is in Advanced Therapy Field with an extensive background in process development for cellular platforms.

Giovanna Alves de Sousa Dutra

Production Supervisor at Vaxxinova

Giovanna Dutra is a Production Supervisor at Vaxxinova's Brazil site with a background in Biotechnology and a Master's degree in Industrial Biotechnology. She has extensive experience in viral vaccine manufacturing, bioprocess development, technology transfer, process scale-up and cell culture-based production for vaccines.

In 5 Days

You have registered for this webinar